Kidney cografts enhance fiber outgrowth from ventral mesencephalic grafts to the 6-OHDA-lesioned striatum, and improve behavioral recovery

Cell Transplantation

Volumn 7, Issue 2, 1998, Pages 197-212

  Granholm, Ann Charlotte ^a   Henry, Stephanie ^a   Hebert, Meleik A ^a   Eken, Servet ^a   Gerhardt, Greg A ^a   Van Horne, Craig ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Basal ganglia; Dopaminergic neurons; Kidney; Neural transplantation; Neurotrophic factors; Nigrostriatal system; Ventral mesencephalon

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; CONFERENCE PAPER; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GRAFT SURVIVAL; KIDNEY DEVELOPMENT; KIDNEY GRAFT; MALE; MESENCEPHALON; NERVE FIBER GROWTH; NERVE TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN TISSUE TRANSPLANTATION; CELL SURVIVAL; CHOLINE O-ACETYLTRANSFERASE; CORPUS STRIATUM; FETAL TISSUE TRANSPLANTATION; KIDNEY TRANSPLANTATION; MALE; MOTOR ACTIVITY; NERVE FIBERS; NERVE GROWTH FACTORS; NEURODEGENERATIVE DISEASES; OXIDOPAMINE; RATS; RATS, INBRED F344; TYROSINE 3-MONOOXYGENASE;

EID: 0031953356     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0963-6897(97)00168-1     Document Type: Conference Paper

References (90)

1. Alexi, T.; Hefti, F. Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons in culture. Neuroscience 55:903-918; 1993.
2. Beck, K.D.; Knusel, B.; Hefti, F. The nature of trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience 52:855-866; 1993.
3. Bergman, H.; Nagy, J.L.; Granholm, A.-C.H. Intracranial transplantation and survival of tuberomammillary histaminergic neurons. Neuroscience 64:61-70; 1995.
4. Björklund, A.; Stenevi, U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177:555-560; 1979.
5. Blottner, D.; Bniggemann, W.; Unsicker, K. Ciliary neurotrophic factor supports target-derived preganglionic sympathetic spinal cord neurons. Neurosci. Lett. 105:316-320; 1989.
6. Bowenkamp, K.E.; Hoffman, A.F.; Gerhardt, G.A.; Henry, M.A.; Biddle, P.T.; Hoffer, B.J.; Granholm, A.-C.H. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355:479-489; 1995.
7. Broadwell, R.D.; Charlton, H.M.; Ebert, P.; Hickey, W.; Shirazi, Y.; Villegas, J.; Wolf, A. Allografts of CNS tissue possess a blood-brain barrier. II. Angiogenesis in solid tissue and cell suspension grafts. Exp. Neurol. 112:1-28; 1991.
8. Broadwell, R.D.; Baker, B.J.; Ebert, P.; Hickey, W.F.; Villegas, J. Intracerebral grafting of solid tissues and cell suspensions: The blood-brain barrier and host immune response. Prog. Brain Res. 91:95-102; 1992.
9. Bäckman, C.; Biddle, P.T.; Ebendal, T.; Friden, P.M.; Gerhardt, G.A.; Henry, M.A.; Mackerlova, L.; Söderström, S.; Strömberg, I.; Walus, L.; Hoffer, B.J.; Granholm, A.Ch.E. Effects of transferrin receptor antibody-NGF conjugate on young and aged septal transplants in oculo. Exp. Neurol. 132:1-15; 1995.
10. Carman, L.S.; Gage, F.H.; Schuhs, C.W. Partial lesion of the substantia nigra: Relation between extent of lesion and rotational behavior. Brain Res. 553:275-283; 1991.
11. Charles, V.; Mufson, E.J.; Friden, P.M.; Bartus, R.T.; Kordower, J.H. Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate. Brain Res. 728:193-203; 1996.
12. Curtis, M.; Bergman, H.; Price, M.L.; Srivastava, N.; Granholm. A.-Ch. Hypothalamic tissue stimulates hippocampal pyramidal neuron survival during development: Evidence from intraocular double transplants. Hippocampus 5:584-594; 1995.
13. Dahl, D.; Bignami, A. Glial fibrillary acidic protein from normal human brain. Purification and properties. Brain Res. 57:343-360; 1973.
14. Date, I.; Notter, M.; Felten, S.; Felten, D. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res. 526:156-160; 1990.
15. Date, I.; Imaoka, T.; Miyoshi, Y.; Ono, T.; Asari, S.; Ohmoto, T. Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. J. Neurosurg. 84:685-689; 1996.
16. Davies, A.M.; Thoenen, H.; Barde, Y.A. The response of chick sensory neurons to brain-derived neurotrophic factor. J. Neurosci. 6:1897-1904; 1986.
17. Deacon, T.; Schumacher, J.; Dinsmore, J.; Thomas, C.; Palmer, P.; Kott, S.; Edge, A.; Penney, D.; Kassissieh, S.; Dempsey, P.; Isacson, O. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. 3:350-353; 1997.
18. Ebendal, T.; Lonnerberg, P.; Pei, G.; Kylberg, A.; Kullander, K.; Persson, H.; Olson, L. Engineering cells to secrete growth factors. J. Neurol. 242(Suppl 1):S5-S7; 1994.
19. Edelman, G.M. Cell adhesion and morphogenesis: The regulator hypothesis. Proc. Natl. Acad. Sci. USA 81:1460-1464; 1984.
20. Emerich, D.F.; Winn, S.R.; Harper, J.; Hammang, J.P.; Baetge, E.E.; Kordower, J.H. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neurons. J. Comp. Neurol. 349:148-164; 1994.
21. Eriksdotter-Nilsson, M.; Skirboll, S.; Ebendal, T.; Hersh, L.; Grassi, J.; Massoulie, J.; Olson, L. NGF treatment promotes development of basal forebrain tissue grafts in the anterior chamber of the eye. Exp. Brain Res. 7:1-10; 1988.
22. Ernsberger, U.; Sendtner, M.; Rohrer, H. Proliferation and differentiation of embryonic chick sympathetic neurons: Effects of ciliary neurotrophic factor. Neuron 2:1275-1284; 1989.
23. Falckh, P.H.; Harkin, L.A.; Head, R.J. Nerve growth factor mRNA content parallels altered sympathetic innervation in the spontaneously hypertensive rat. Clin. Exp. Pharmacol. Phys. 19:541-545; 1992.
24. Ferarri, G.;, Minozzi, M.; Toffano, G.; Leon, A.; Skaper, S. Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev. Biol. 133:140-147; 1989.
25. Freed, W.J. Substantia nigra grafts and Parkinson's disease: From animal experiments to human therapeutic trials. Restor. Neurol. Neurosci. 3:109-134; 1991.
26. Freed, C.R.; Breeze, R.E.; Rosenberg, N.L.; Schneck, S.A.; Kriek, E.; Qi, J.-X.; Lone, T.; Zhang, Y.-B.; Snyder, J.A.; Wells, T.H.; Olson Ramige, L.; Thompson, L.; Maziotta, J.C.; Huang, S.C.; Grafton, S.T.; Brooks, D.; Sawle, G.; Schroter, G.; Ansari, A.A. Survival of implanted dopamine cells and neurological improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327:1549-1555; 1992.
27. Freeman, T.B.; Sanberg, P.R.; Nauert, G.M. The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant. 4:141-154; 1995.
28. Friedman, W.J.; Ibanez, C.F.; Hallbook, F.; Persson, H.; Cain, L.D.; Dreyfus, C.F.; Black, I.B. Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp. Neurol. 119:72-78; 1993.
29. Gash, D.M.; Zhang, Z.; Ovadia, A.; Cass, W.A.; Yi, A.; Simmerman, L.; Russell, D.; Martin, D.; Lapchak, P.A.; Collins, F.; Hoffer, B.J.; Gerhardt, G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252-255; 1996.
30. Giacobini, M.M.J.; Almström, S.; Funa, K.; Olson, L. Differential effects of PDGF isoforms on dopamine neurons in vivo: AA enhances formation, -BB supports cell survival. Neuroscience 57:923-929; 1993.
31. Giacobini, M.M.J.; Stromberg, I.; Almstrom, S.; Cao, Y.; Olson, L. Fibroblast growth factor enhance dopamine fiber formation from nigral grafts. Dev. Brain Res. 75:65-73; 1993.
32. Granholm, A.-Ch.; Curtis, M..; Diamond, D.M.; Branch, BJ.; Heman, K.L.; Rose, G.M. Development of an intact blood-brain barrier in brain tissue transplants is dependent on the site of transplantation. Cell Transplant. 5:305-314; 1996.
33. Granholm, A.-Ch.; Mott, J.L.; Bowenkamp, K.; Eken, S.; Henry, S.; Hoffer, B.J.; Lapchak, P.A.; van Hornee, C.; Gerhardt, G.A. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp. Brain Res. 116:29-38; 1997.
34. Hammerman, M.R. Growth factors in renal development. Semin. Nephrol. 15:291-299; 1995.
35. Hartikka, J.; Hefti, H. Comparison of nerve growth factor's effects on development of septum, striatum and nucleus basalis cholinergic neurons in vitro. J. Neurosci. Res. 21:352-364; 1988.
36. Hitchcock, E. Current trends in neural transplantation. Neurol. Res. 17:33-37; 1995.
37. Hoffer, B.J.; Hoffman, A.F.; Bowenkamp, K.; Huettl, P.; Hudson, J.; Martin, D.; Lin, L.-F.; Gerhardt, G.A. Glial cell-line derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182:107-111; 1994.
38. Hoffman, A.F.; van Horne, C.G.; Eken, S.; Hoffer, B.J.; Gerhardt, G.A. In vivo microdialysis studies of somatodendritic dopamine release in the rat substantia nigra: Effects of unilateral 6-OHDA lesions and GDNF. Exp. Neurol. 147:130-141; 1997.
39. Hudson, J.L.; van Hornee, C.G.; Strömberg, I.; Brock, S.; Clayton, G.; Masserano, J.; Hoffer, B.J.; Gerhardt, G.A. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 626:167-174; 1993.
40. Hudson, J.L.; Levin, D.R.; Hoffer, B.J. A 16-channel automated rotometer system for reliable measurement of turning behavior in 6-hydroxydopamine lesioned and transplanted rats. Cell Transplant. 2:507-514; 1993.
41. Hyman, C.; Hofer, M.; Barde, Y.-A.; Juhasz, M.; Jancoupolous, G.; Squinto, S.; Lindsay, R. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232; 1991.
42. Hynes, M.; Berkemeyer, L.; Poulsen, K.; Hefti, F.; Rosenthal, A. Neurotrophin 4/5 promotes survival of dopaminergic neurons and is present in embryonic striatum. Soc. Neurosci. Abstr. 19:275.11; 1993.
43. Kapuschinski, M.; Charcar, F.; Innes, B.; Mitchell, G.A.; Norman, T.L.; Harrap, S.B. Nerve growth factor gene and hypertension in spontaneously hypertensive rats. J. Hypertens. 14:191-197; 1996.
44. Karavanov, A.; Sainio, K.; Palgi, J.; Saarma, M.; Saxen, L.; Sariola, H. Neurotrophin 3 rescues neuronal precursors from apoptosis and promotes neuronal differentiation in the embryonic metanephric kidney. Proc. Natl. Acad. Sci. USA 92:11279-11283; 1995.
45. Knusel, B.; Michel, P.P.; Schwaber, J.S.; Hefti, F. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J. Neurosci. 10:558-570; 1990.
46. Knusel, B.; Winslow, J.; Rosenthal, A.; Burton, L.; Seid, B.; Nikolicks, K.; Hefti, F. Promotion of central cholinergic and dopaminergic neuron differentiation by brainderived neurotrophic factor but not neurotrophin-3. Proc. Natl. Acad. Sci. USA 88:961-965; 1991.
47. Kordower, J.H.; Charles, V.; Bayer, R.; Bartus, R.T.; Putney, S.; Walus, L.R.; Friden, P.M. Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington's disease. Proc. Natl. Acad. Sci. USA 91:9077-9080; 1994.
48. Kordower, J.H.; Freeman, T.B.; Snow, B.J.; Vingerhoets, F.J.; Mufson, E.J.; Sanberg, P.R.; Hauser, R.A.; Smith, D.A.; Nauert, G.M.; Perl, D.P. Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:118-124; 1995.
49. Lindner, M.D.; Winn, S.R.; Baetge, E.E.; Hammang, J.P.; Gentile, F.T.; Doherty, E.; McDermot, P.E.; Frydel, B.; Ullman, M.D.; Schallert, T. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp. Neurol. 132:62-76; 1995.
50. Lindvall, O.; Rehncrona, S.; Gustaavii, B.; Brundin, P.; Åstedt B.; Widner, H.; Lindholm, T.; Björklund, A.; Leenders, K.; Rothwell, J. Fetal dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet 8626-8627: 1483-1484; 1988.
51. Lindvall, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustaavii, B.; Frackowiak, R.; Leenders, K.L.; Sawle, G.; Rothwell, J.C.; Marsden, C.D. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:575-577; 1990.
52. Lopez-Lozano, J.J.; Bravo, G.G.; Brera, B.; Dargallo, J.; Salmean, J.; Uria, J.; Insausti, J.; Millan, I. Long-term follow up in 10 Parkinson's disease patients subjected to fetal brain grafting into a cavity in the caudate nucleus: The Clinica Puerta de Hierro experience. CPH Neural Transplantation Group. Transplant. Proc. 27:1395-1400; 1995.
53. MacGrogan, D.; Saint-Andre, J.P.; Dicou, E. Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. J. Neurochem. 59:1381-1391; 1992.
54. Magal, E.; Burnham, P.; Varon, S.; Louis, J.-C. Convergent regulation by ciliary neurotrophic factor and dopamine of tyrosine hydroxylase expression in cultures of rat substantia nigra. Neuroscience 52:867-881; 1993.
55. Morrison, R.S.; Sharma, A.; De Vellise, J.; Bradshaw, R.A. Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. Natl. Acad. Sci. USA 83:7537-7541; 1986.
56. Morse, J.K.; Wiegand, S.J.; Anderson, K.; You, Y.; Cai, N.; Carnahan, J.; Miller, J.; DiStefano, P.S.; Altar, C.A.; Lindsay, R.M.; Alderson, R.F. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J. Neurosci. 13:4146-4156; 1993.
57. Mufson, E.J.; Kroin, J.S.; Sobreviela, T.; Burke, M.A.; Kordower, J.H.; Penn, R.D.; Miller, J.A. Intrastriatal infusions of brain-derived neurotrophic factor: Retrograde transport and colocalization with dopamine-containing substantia nigra neurons in rat. Exp. Neurol. 129:15-26; 1994.
58. Mufson, E.J.; Kroin, J.S.; Liu, Y.; Sobreviela, T.; Penn, R.D.; Miller, J.A.; Kordower, J.H. Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: Distribution, retrograde transport and co-localization with substantia nigra dopaminecontaining neurons. Neuroscience 71:179-191; 1996.
59. Nikkah, G.; Odin, P.; Smits, A.; Tingström, A.; Ohtberg, A.; Brundin, P.; Funa, K.; Lindvall, O. Platelet-derived growth factor promotes survival of rat and human mesencephalic dopamine neurons in culture. Exp. Brain Res. 92:516-523; 1993.
60. Nikkah, G.; Brandeis, A. Neurotransplantation in Parkinson disease; Experimental and clinical results of functional reconstruction of the dopaminergic system. Zentralbl. Neurochir. 56:153-160; 1995.
61. Nosrat, C.A.; Tomac, A.; Lindqvist, E.; Lindskog, S.; Humpel, C.; Strömberg, I.; Ebendal, T.; Hoffer, B.J.; Olson, L. Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res. 286:191-207; 1996.
62. Ohta, K.; Hara, H.; Hayashi, K.; Itoh, N.; Ohi, T.; Ohta, M. Tissue expression of rat ciliary neurotrophic factor (CNTF) mRNA and production of the recombinant CNTF. Biochem. Mol. Biol. Int. 35:283-290; 1995.
63. Olson, L.; Seiger, Å.; Strömberg, I. Intraocular transplantation in rodents: A detailed account of the procedure and examples of its use in neurobiology with special reference to brain tissue grafting. Adv. Cell. Neurobiol. 4:407-440; 1983.
64. Olson, L.; Backlund, E.-O.; Ebendal, T.; Freedman, R.; Hamberger, B.; Hansson, P.; Hoffer, B.; Lindblom, U.; Meyerson, B.; Strömberg, I.; Sydow, O.; Seiger, Å. Intraputamial infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease: One year follow up of first clinical trial. Arch. Neurol. 48:373-381; 1991.
65. Otto, D.; Unsicker, K. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP treated mice. J. Neurosci. 10:1912-1921; 1990.
66. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates, 2nd ed. New York: Academic Press; 1986.
67. Perlow, M.J.; Freed, W.J.; Hoffer, B.J.; Seiger, Å.; Olson, L.; Wyatt, R.J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643-647; 1979.
68. Price, M.L.; Hoffer, B.J.; Granholm, A.-Ch. Effects of GDNF on fetal septal forebrain transplants in oculo. Exp. Neurol. 141:181-189; 1996.
69. Rioux, L.; Gaudin, D.; Bui, L.; Gregoire, L.; DiPaolo, T.; Bedard, P. Correlation of functional recovery after a 6-hydroxydopamine lesion with survival of grafted fetal neurons and release of dopamine in the striatum of the rat. Neuroscience 40:123-131; 1991.
70. Rosenstein, J.M. Why do neural transplants survive? An examination of some metabolic and pathophysiological considerations in neural transplantatione. Exp. Neurol. 133:1-6; 1995.
71. Ruithauser, U.; Jessell, T.M. Cell adhesion molecules in vertebrate neural development. Physiol. Rev. 68:819-857; 1988.
72. Sanberg, P.R.; Othberg, A.I.; Borlongan, C.V.; Saporta, S.; Anton, A.; Freeman, T.B.; Cahill, D.W.; Allen, R.C.; Cameron, D.F. Transplantation of testis-derived Sertoli cells into the mammalian brain. Transplant. Proc. 29: 1926-1928; 1997.
73. Sauer, H.; Rosenblad, C.; Björklund, A. Glial cell linederived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA 92:8935-8939; 1995.
74. Sautter, J.; Kupsch, A.; Oertel, W.H.; Earl, C.D. Neuronal transplantation in animal models of Parkinson's disease: In vivo voltammetry, tissue cryopreservation and immunology. Zentralbl. Neurochir. 56:161-167; 1995.
75. Schnell, L.; Schwab, M.B. Axonal regeneration in the rat spinal cord produced by an antibody against myelinassociated neunte growth inhibitors. Nature 343:269-272; 1990.
76. Sinclair, S.R.; Clive, C.A.; Svendsen, N.; Torres, E.M.; Fawcett, J.W.; Dunnett, S.B. GDNF enhances dopaminergic cell survival and fiber outgrowth in embryonic nigral grafts. Neuroreport 7:2547-2552; 1996.
77. Strömberg, I.; Johnson, S.; Hoffer, B.J.; Olson, L. Reinnervation of dopamine-denervated striatum by substantia nigra transplants: Immunohistochemical and electrophysiological correlates. Neuroscience 14:981-990; 1985.
78. Strömberg, I.; Björklund, L.; Johansson, M.; Tomac, A.; Collins, F.; Olson, L.; Hoffer, B.J.; Humpel, C. Glial cell-line derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124:401-412; 1993.
79. Suvanto, P.; Hiltunen, J.O.; Arumae, U.; Moshnyakov, M.; Sariola, H.; Sainio, K.; Saarma, M. Localization of glial cell line-derived neurotrophic factor (GDNF) mRNA in embryonic rat by in situ hybridization. Eur. J. Neurosci. 8:816-822; 1996.
80. Tahira, E.; Takaha, N.; Taniura, H.; Kim, C.H.; Miki, N. Molecular cloning and functional expression of gicerin, a novel cell adhesion molecule that binds to neurite out-growth factor. Neuron 12:861-872; 1994.
81. Takeichi, M. The cadherins: Cell-cell adhesion molecules controlling animal morphogenesis. Development 102:639-655; 1988.
82. Thoenen, H.; Barde, Y.A. Physiology of nerve growth factor. Physiol. Rev. 60:1284-1335; 1980.
83. Timmusk, T.; Belluardo, N.; Metsis, M.; Persson, H. Widespread and developmentally regulated expression of neurotrophin 4 mRNA in rat brain and peripheral tissues. Eur. J. Neurosci. 5:605-613; 1993.
84. Trupp, M.; Ryden, M.; Jornvall, H.; Funakoshi, H.; Timmusk, T.; Arenas, E.; Ibanez, C.F. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130:137-148; 1995.
85. Tuttle, J.B.; Stewart, J.S.; Spitsbergen, J.M.; MacCarthy, R.M. Nerve growth factor, vessel innervation and hypertensive progression in the inbred Dahl SS/Jr and SR/Jr rats. Clin. Exp. Pharmacol. Phys. (Suppl.) 1:S23-S25; 1995.
86. Ungerstedt, U.; Herrera-Marschitz, M. Behavioral pharmacology of dopamine receptor mechanisms. In: Stjaerne, L.; Hedqvist, P.; Lagerkrantz, H.; Wenmalm, A., eds. Chemical neurotransmission: 75 years. New York: Academic Press; 1981:481-494.
87. van Hornee, C.G.; Strömberg, I.; Young, D.; Olson, L.; Hoffer, B. Functional enhancement of intrastriatal dopamine-containing grafts by the co-transplantation of sciatic nerve tissue in 6-hydroxydopamine-lesioned rats. Exp. Neurol. 113:143-154; 1991.
88. Widmer, H.; Alexi, T.; Valverde, J.; Knusel, B.; Hefti, F. TGFα stimulation of phosphatidylinositol hydrolysis in mesencephalic cultures requires neuron-glia interactions. Neuroreport 4:407-410; 1993.
89. Yurek, D.M.; Lu, W.; Hipkens, S.; Wiegand, S.J. BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine cells. Exp. Neurol. 137:105-118; 1996.
90. Zhou, X.F.; Rushm R.A. Localization of neurotrophin 3-like immunreactivity in peripheral tissues of the rat. Brain Res. 621:189-199; 1993.